These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 26065001

  • 1. Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.
    Magy L, Kaboré R, Mathis S, Lebeau P, Ghorab K, Caudie C, Vallat JM.
    J Immunol Res; 2015; 2015():450391. PubMed ID: 26065001
    [Abstract] [Full Text] [Related]

  • 2. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
    Kuijf ML, Eurelings M, Tio-Gillen AP, van Doorn PA, van den Berg LH, Hooijkaas H, Stork J, Notermans NC, Jacobs BC.
    Neurology; 2009 Sep 01; 73(9):688-95. PubMed ID: 19720975
    [Abstract] [Full Text] [Related]

  • 3. Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
    Pascual-Goñi E, Martín-Aguilar L, Lleixà C, Martínez-Martínez L, Simón-Talero MJ, Díaz-Manera J, Cortés-Vicente E, Rojas-García R, Moga E, Juárez C, Illa I, Querol L.
    Sci Rep; 2019 Apr 16; 9(1):6155. PubMed ID: 30992531
    [Abstract] [Full Text] [Related]

  • 4. [Polyneuropathy involving cranial nerves associated with monoclonal IgM antibodies with anti-MAG/SGPG/SGPLG/sulfatides activity].
    Drouet A, Caudie C, Vallat JM, Ruel JH, Felten D, Guilloton L, Giraud P.
    Rev Neurol (Paris); 2006 Jun 16; 162(6-7):760-6. PubMed ID: 16840988
    [Abstract] [Full Text] [Related]

  • 5. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
    Larue S, Bombelli F, Viala K, Neil J, Maisonobe T, Bouche P, Musset L, Fournier E, Léger JM.
    Eur J Neurol; 2011 Jun 16; 18(6):899-905. PubMed ID: 21199182
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-SGPG antibody in CIDP: nosological position of IgM anti-MAG/SGPG antibody-associated neuropathy.
    Tagawa Y, Yuki N, Hirata K.
    Muscle Nerve; 2000 Jun 16; 23(6):895-9. PubMed ID: 10842265
    [Abstract] [Full Text] [Related]

  • 10. Obinutuzumab, a new anti-CD20 antibody, and chlorambucil are active and effective in anti-myelin-associated glycoprotein antibody polyneuropathy.
    Briani C, Visentin A, Salvalaggio A, Cacciavillani M, Trentin L.
    Eur J Neurol; 2019 Feb 16; 26(2):371-375. PubMed ID: 30315672
    [Abstract] [Full Text] [Related]

  • 11. Nerve ultrasound findings in neuropathy associated with anti-myelin-associated glycoprotein antibodies.
    Lucchetta M, Padua L, Granata G, Luigetti M, Campagnolo M, Dalla Torre C, Coraci D, Sabatelli M, Briani C.
    Eur J Neurol; 2015 Jan 16; 22(1):193-202. PubMed ID: 25174585
    [Abstract] [Full Text] [Related]

  • 12. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
    Garces-Sanchez M, Dyck PJ, Kyle RA, Zeldenrust S, Wu Y, Ladha SS, Klein CJ.
    Muscle Nerve; 2008 Apr 16; 37(4):490-5. PubMed ID: 18236455
    [Abstract] [Full Text] [Related]

  • 13. Chronic inflammatory demyelinating polyneuropathy associated with dysglobulinemia: a peripheral nerve biopsy study in 18 cases.
    Vital A, Lagueny A, Julien J, Ferrer X, Barat M, Hermosilla E, Rouanet-Larrivière M, Henry P, Bredin A, Louiset P, Herbelleau T, Boisseau C, Guiraud-Chaumeil B, Steck A, Vital C.
    Acta Neuropathol; 2000 Jul 16; 100(1):63-8. PubMed ID: 10912921
    [Abstract] [Full Text] [Related]

  • 14. NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy.
    Benedetti L, Facco M, Franciotta D, Dalla Torre C, Campagnolo M, Lucchetta M, Boscaro E, Ermani M, Del Sette M, Berno T, Candiotto L, Zambello R, Briani C.
    J Neurol Sci; 2013 Aug 15; 331(1-2):86-9. PubMed ID: 23764364
    [Abstract] [Full Text] [Related]

  • 15. Chronic demyelinating neuropathy with anti-myelin-associated glycoprotein antibody without any detectable M-protein.
    Sakamoto Y, Shimizu T, Tobisawa S, Isozaki E.
    Neurol Sci; 2017 Dec 15; 38(12):2165-2169. PubMed ID: 28980134
    [Abstract] [Full Text] [Related]

  • 16. Anti-MAG IgM: differences in antibody tests and correlation with clinical findings.
    Matà S, Ambrosini S, Saccomanno D, Biagioli T, Carpo M, Amantini A, Giannini F, Barilaro A, Toscani L, Del Mastio M, Comi GP, Sorbi S.
    Neurol Sci; 2020 Feb 15; 41(2):365-372. PubMed ID: 31654362
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies.
    Vallat JM, Magy L, Ciron J, Corcia P, Le Masson G, Mathis S.
    Expert Rev Neurother; 2016 Sep 15; 16(9):1111-9. PubMed ID: 27267749
    [Abstract] [Full Text] [Related]

  • 18. Characterization of neuropathies associated with elevated IgM serum levels.
    Goldfarb AR, Sander HW, Brannagan TH, Magda P, Latov N.
    J Neurol Sci; 2005 Feb 15; 228(2):155-60. PubMed ID: 15694197
    [Abstract] [Full Text] [Related]

  • 19. Familial polyneuropathy with anti-myelin-associated glycoprotein antibodies.
    Srinivasan J, Tseng VG, Yang D, Harris BT, Jones HR, Stommel EW.
    Neurology; 2005 Jun 14; 64(11):1983-4. PubMed ID: 15955965
    [No Abstract] [Full Text] [Related]

  • 20. Binding specificity of anti-HNK-1 IgM M-protein in anti-MAG neuropathy: possible clinical relevance.
    Hamada Y, Hirano M, Kuwahara M, Samukawa M, Takada K, Morise J, Yabuno K, Oka S, Kusunoki S.
    Neurosci Res; 2015 Feb 14; 91():63-8. PubMed ID: 25450311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.